secwatch.observer — SEC 8-K summary
======================================

Issuer:     Clene Inc. (CLNN)
CIK:        0001822791
Form:       8-K
Filed at:   2023-03-17T23:59:59+00:00
Accession:  0001437749-23-007054
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Clene CMO retiring Apr 1; Dr. Benjamin Greenberg named Head of Medical
----------------------------------------------------------------------

- Robert Glanzman, M.D., Chief Medical Officer, retiring effective April 1, 2023; will provide consulting services at $300/hour for one year.
- Stock options granted pre-retirement continue vesting during the one-year consulting term; unvested options expire per 2020 Stock Plan.
- Benjamin Greenberg, M.D., M.H.S., appointed Head of Medical effective April 1, 2023; continues as neurology professor at UT Southwestern.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822791/000143774923007054/0001437749-23-007054-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822791/000143774923007054/clnn20230206_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-007054

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer